anti-HIV-1 P24 antibody product blog
Tags: Antibody; Monoclonal Antibody; HIV-1 p24; anti-HIV-1 p24 antibody;
The HIV-1 P24 n/a (Catalog #MBS592031) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The mAb anti- HIV-1 P24 (Core Protein) reacts with Human immunodeficiency virus. Others not tested.No cross activity with HIV-1 GP41 and HIV-2 GP36 was found. and may cross-react with other species as described in the data sheet. MyBioSource\'s HIV-1 P24 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB).
ELISA: The antibody reacts with recombinant HIV-1 p24 in ELISA.
Western Blot: The antibody, when used at concentration of 0.1-1.0 mg/mL will allow visualization of 100ng/lane recombinant HIV-1 p24. Researchers should empirically determine the suitability of the HIV-1 P24 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal antibody (MAb) to HIV-1 P24 (core protein), Protein G affinity purified.
Target Protein: HIV-1 p24
Immunogen: Purified recombinant HIV-1 p24 (core protein)
Myeloma: Sp2/0-Ag14
Light Chain: Kappa
Reconstitution: Double distilled water is recommended to adjust the final concentration to 1.00mg/mL. Research Area: Virology. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing HIV-1 P24 are readily searchable from our website. Different antibodies against the same target such as HIV-1 P24 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.